AAAAAA

   
Results: 1-10 |
Results: 10
Autologous stem-cell transplantation for Hodgkin's disease: Results and prognostic factors in 494 patients from the Grupo Espanol de Linfomas/Transplante Autolog de Medula Osea Spanish Cooperative Group
Authors: Sureda, A Arranz, R Iriondo, A Carreras, E Lahuerta, JJ Garcia-Conde, J Jarque, I Caballero, MD Ferra, C Lopez, A Garcia-Larana, J Cabrera, R Carrera, D Ruiz-Romero, MD Leon, A Rifon, J Diaz-Mediavilla, J Mataix, R Morey, M Moraleda, JM Altes, A Lopez-Guillermo, A de la Serna, J Fernandez-Ranada, JM Sierra, J Conde, E
Citation: A. Sureda et al., Autologous stem-cell transplantation for Hodgkin's disease: Results and prognostic factors in 494 patients from the Grupo Espanol de Linfomas/Transplante Autolog de Medula Osea Spanish Cooperative Group, J CL ONCOL, 19(5), 2001, pp. 1395-1404
Additional cytogenetic changes do not influence the outcome of patients with newly diagnosed acute promyelocytic leukemia treated with an ATRA plus anthracycline-based protocol. A report from the Spanish group PETHEMA
Authors: Hernandez, JM Martin, G Gutierrez, NC Cervera, J Ferro, MT Calasanz, MJ Martinez-Climent, JA Luno, E Tormo, M Rayon, C Diaz-Mediavilla, J Gonzalez, M Gonzalez-San Miguel, JD Perez-Equiza, K Rivas, C Esteve, J Alvarez, MD Odriozola, J Ribera, JM Sanz, MA
Citation: Jm. Hernandez et al., Additional cytogenetic changes do not influence the outcome of patients with newly diagnosed acute promyelocytic leukemia treated with an ATRA plus anthracycline-based protocol. A report from the Spanish group PETHEMA, HAEMATOLOG, 86(8), 2001, pp. 807-813
Pretreatment characteristics and clinical outcome of acute promyelocytic leukaemia patients according to the PML-RAR alpha isoforms: a study of the PETHEMA group
Authors: Gonzalez, M Barragan, E Bolufer, P Chillon, C Colomer, D Borstein, R Calasanz, MJ Gomez-Casares, MT Villegas, A Marugan, I Roman, J Martin, G Rayon, C Deben, G Tormo, M Diaz-Mediavilla, J Esteve, J Gonzalez-San Miguel, J Rivas, C Perez-Equiza, K Garcia-Sanz, R Capote, FJ Ribera, JM Arias, J Leon, A Sanz, MA
Citation: M. Gonzalez et al., Pretreatment characteristics and clinical outcome of acute promyelocytic leukaemia patients according to the PML-RAR alpha isoforms: a study of the PETHEMA group, BR J HAEM, 114(1), 2001, pp. 99-103
Early immunophenotypical evaluation of minimal residual disease in acute myeloid leukemia identifies different patient risk groups and may contributeto postinduction treatment stratification
Authors: San Miguel, JF Vidriales, MB Lopez-Berges, C Diaz-Mediavilla, J Gutierrez, N Canizo, C Ramos, F Calmuntia, MJ Perez, JJ Gonzalez, M Orfao, A
Citation: Jf. San Miguel et al., Early immunophenotypical evaluation of minimal residual disease in acute myeloid leukemia identifies different patient risk groups and may contributeto postinduction treatment stratification, BLOOD, 98(6), 2001, pp. 1746-1751
Remission status defined by immunofixation vs. electrophoresis after autologous transplantation has a major impact on the outcome of multiple myelomapatients
Authors: Lahuerta, JJ Martinez-Lopez, J de la Serna, J Blade, J Grande, C Alegre, A Vazquez, L Garcia-Larana, J Sureda, A de la Rubia, J Conde, E Martinez, R Perez-Equiza, K Moraleda, JM Leon, A Besalduch, J Cabrera, R Gonzalez-San Miguel, JD Morales, A Garcia-Ruiz, JC Diaz-Mediavilla, J San-Miguel, J
Citation: Jj. Lahuerta et al., Remission status defined by immunofixation vs. electrophoresis after autologous transplantation has a major impact on the outcome of multiple myelomapatients, BR J HAEM, 109(2), 2000, pp. 438-446
Conditioning regimens in autologous stem cell transplantation for multiplemyeloma: a comparative study of efficacy and toxicity from the Spanish Registry for Transplantation in Multiple Myeloma
Authors: Lahuerta, JJ Martinez-Lopez, J Grande, C Blade, J de la Serna, J Alegre, A Garcia-Larana, J Caballero, D Sureda, A de la Rubia, J Alvarez, AM Marin, J Escudero, A Conde, E Perez-Equiza, K Ruiz, JCG Moraleda, JM Leon, A Bargay, J Cabrera, R Hernandez-Garcia, MT Diaz-Mediavilla, J San Miguel, J
Citation: Jj. Lahuerta et al., Conditioning regimens in autologous stem cell transplantation for multiplemyeloma: a comparative study of efficacy and toxicity from the Spanish Registry for Transplantation in Multiple Myeloma, BR J HAEM, 109(1), 2000, pp. 138-147
Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups
Authors: Sanz, MA Lo Coco, F Martin, G Avvisati, G Rayon, C Barbui, T Diaz-Mediavilla, J Fioritoni, G Gonzalez, JD Liso, V Esteve, J Ferrara, F Bolufer, P Bernasconi, C Gonzalez, M Rodeghiero, F Colomer, D Petti, MC Ribera, JM Mandelli, F
Citation: Ma. Sanz et al., Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups, BLOOD, 96(4), 2000, pp. 1247-1253
Acute promyelocytic leukemia relapse in the central nervous system during hematologic and molecular remission
Authors: Anguita, E Villegas, A Gonzalez, FA Diaz-Mediavilla, J Lo Coco, F
Citation: E. Anguita et al., Acute promyelocytic leukemia relapse in the central nervous system during hematologic and molecular remission, AM J HEMAT, 60(2), 1999, pp. 170-171
Association between persistence of the BCR/ABL rearrangement and relapse in adult patients with acute lymphoblastic leukaemia
Authors: Anguita, E Villegas, A Gonzalez, FA del Potro, E Martinez, R Alvarez, A Diaz-Mediavilla, J Ferro, MT Espinos, D
Citation: E. Anguita et al., Association between persistence of the BCR/ABL rearrangement and relapse in adult patients with acute lymphoblastic leukaemia, MED CLIN, 112(13), 1999, pp. 481-484
A modified AIDA protocol with anthracycline-based consolidation results inhigh antileukemic efficacy and reduced toxicity in newly diagnosed PML/RARalpha-positive acute promyelocytic leukemia
Authors: Sanz, MA Martin, G Rayon, C Esteve, J Gonzalez, M Diaz-Mediavilla, J Bolufer, P Barragan, E Terol, MJ Gonzalez, JD Colomer, D Chillon, C Rivas, C Gomez, T Ribera, JM Bornstein, R Roman, J Calasanz, MJ Arias, J Alvarez, C Ramos, F Deben, G
Citation: Ma. Sanz et al., A modified AIDA protocol with anthracycline-based consolidation results inhigh antileukemic efficacy and reduced toxicity in newly diagnosed PML/RARalpha-positive acute promyelocytic leukemia, BLOOD, 94(9), 1999, pp. 3015-3021
Risultati: 1-10 |